Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 23;18(6):e0287454.
doi: 10.1371/journal.pone.0287454. eCollection 2023.

Demonstration project of oral TDF-containing PrEP, administered, once-daily orally to men having sex with men (MSM) and transgender women (TGW) in India: Study protocol

Seema Sahay  1 , Sampada Bangar  2 , Nomita Chandhiok  3
Affiliations

Demonstration project of oral TDF-containing PrEP, administered, once-daily orally to men having sex with men (MSM) and transgender women (TGW) in India: Study protocol

Seema Sahay et al. PLoS One. .

Abstract

Background: India has successfully reduced Human Immuno-deficiency Virus (HIV) incidence, with a 66% decline since the year 2000 has been seen; however, control among Men having sex with Men (MSM) and transgender women (TGW) remains a critical challenge. Oral Pre-Exposure Prophylaxis (PrEP) may help close a critical HIV prevention gap for MSM and TGW in India; however, no studies to date have evaluated the feasibility of oral PrEP among MSM and TGW in India.

Methods: The proposed study aims at understanding the implementation of the provision of daily oral-Tenofovir (TDF) containing PrEP among MSM and TGW through the clinic and community-based delivery models in Pune, Maharashtra, and Jalandhar, Punjab respectively in India. The study aims at estimating PrEP adherence, facilitators, and barriers to PrEP use, retention, acceptability, and willingness to pay for PrEP. After the screening, eligible participants (n = 600) will receive PrEP medicines and will be monitored quarterly for HIV, STIs, and renal and liver toxicity for 12 months as per the schedule of events. The primary outcomes of interest are PrEP acceptability, PrEP adherence, retention rate, adverse medical events, and sexual behavioural changes with PrEP use and breakthrough infections while on PrEP. The study will assess the feasibility of two service delivery models; however, the data from the two service delivery models will be analyzed independently and will not be compared for feasibility and other outcome indicators. The study has been initiated after obtaining appropriate regulatory approvals.

Discussion: PrEP is efficacious in preventing HIV among high-risk population however there are scarce data on providing PrEP to MSM and TGW. The study will provide critical evidence to programs and policymakers on the implementation of PrEP in a "real world" setting, among MSM and TGW in India including identifying populations that can benefit most from this additional HIV prevention intervention along with acceptable delivery strategies and means of support for adherence.

Trial registration: Not applicable being a demonstration project. Efficacy is already proven.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Study implementation flow chart.
Fig 2
Fig 2. Schedule of events for the PrEP demonstration project.
See this image and copyright information in PMC

References

    1. National AIDS Control Organization & ICMR-National Institute of Medical Statistics (2020). India HIV Estimates 2019: Report. New Delhi: NACO, Ministry of Health and Family Welfare, Government of India https://www.aidsdatahub.org/sites/default/files/resource/india-hiv-estim... accessed on 09 Jun 2023
    1. National AIDS Control Organization (2017). HIV Sentinel Surveillance: Technical Brief, India 2016–17. New Delhi: NACO, Ministry of Health and Family Welfare, Government of India. https://naco.gov.in/sites/default/files/HIV%20SENTINEL%20SURVEILLANCE_06... accessed on 09 June 2023.
    1. Solomon SS MS, Srikrishnan AK, Vasudevan CK, Mcfall AM, Balakrishnan P, Anand S, et al. High HIV prevalence and incidence among men who have sex with men (MSM) across 12 cities in India. AIDS. 2015;29(6):723. - PMC - PubMed
    1. National AIDS Control Organisation,. Annual report. Ministry of Health & Family Welfare GoI, 2014–15 https://naco.gov.in/sites/default/files/annual_report%20_NACO_2014-15_0.pdf accessed on 9 Jun 2023.
    1. National AIDS Control Organization (2022). Consolidating the Evidence, Building the Future: Consultation meeting on Integrated and Enhanced Epidemiology Under the National AIDS & STD Control Programme in India. Report of the National Consultation Meeting (27–29 August 2021). New Delhi: NACO, Ministry of Health and Family Welfare, Government of India https://naco.gov.in/sites/default/files/National_Consultaion_Report_On_I... accessed on 9 Jun 2023

Publication types

Substances